PARAMUS, N.J.–(BUSINESS WIRE) July 20, 2021 –The U.S. Food and Drug Administration (FDA) has granted…
View More FDA Approves Octapharma’s Octagam 10% for Adult Dermatomyositis
Home »
FDA Approves Kerendia
FDA Approves Kerendia (finerenone) for the Treatment of Patients with Chronic Kidney Disease Associated with…
View More FDA Approves Kerendia
FDA Approves Camcevi
FDA Approves Camcevi (leuprolide mesylate) for the Treatment of Advanced Prostate Cancer TAIPEI, May 26,…
View More FDA Approves Camcevi
FDA Approves Nextstellis
FDA Approves Nextstellis (drospirenone and estetrol) Oral Contraceptive for Birth Control 15 April 2021, Adelaide,…
View More FDA Approves Nextstellis
FDA Approves Qelbree
FDA Approves Qelbree (viloxazine) for the Treatment of ADHD ROCKVILLE, Md., April 02, 2021 (GLOBE NEWSWIRE) — Supernus…
View More FDA Approves Qelbree
Families With Sick Kids on Medicaid Seek Easier Access to Out-of-State Hospitals
Three-year-old Elizabeth Zakutansky was born with a rare genetic condition that causes multiple seizures. Her…
View More Families With Sick Kids on Medicaid Seek Easier Access to Out-of-State Hospitals
KHN’s ‘What the Health?’: Planning for Round Two
Can’t see the audio player? Click here to listen on SoundCloud. Congress is out of session,…
View More KHN’s ‘What the Health?’: Planning for Round Two
FDA Approves Breyanzi
FDA Approves Breyanzi (lisocabtagene maraleucel) CAR-T Cell Therapy for Adults with Relapsed or Refractory Large…
View More FDA Approves Breyanzi
Terry White Chemists Anastrozole
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. TERRY WHITE…
View More Terry White Chemists Anastrozole
Daktarin Cream
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. DAKTARIN Cream…
View More Daktarin Cream